BETERNet Notch Signaling and Novel Biomarkers for Barretts Esophagus

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2018-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research study hopes to identify new molecular markers in the tissue of Barrett's esophagus that will help physicians better understand and manage this condition. Patients undergoing an upper endoscopy will be asked to complete a gastroesophageal reflux disease (GERD) questionnaire, provide a blood sample and allow additional biopsies to be taken during the procedure.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Influence of Acid Reflux on Stromal Epithelial Interaction in Barrett's Esophagus

NCT01281618

Barrett's Esophagus

COMPLETED

Barrett's Esophagus in Patients with GERD

NCT06897540

Barrett Esophagus

NOT_YET_RECRUITING NA

Cell Marker Predictors in Barrett's Esophagus

NCT03316053

Barrett's Esophagus Without Dysplasia

ACTIVE_NOT_RECRUITING

Screening for Barrett's Esophagus in Otolaryngology Patients

NCT00695227

Extraesophageal Symptoms Cough Throat Clearing +2 more

COMPLETED NA

Acetic Acid for the Detection of Esophageal Neoplasms

NCT04054713

Barretts Esophagus With Low Grade Dysplasia Dysplasia Intestinal Metaplasia

SUSPENDED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research study hopes to identify new molecular markers in the tissue of Barrett's esophagus that will help physicians better understand and manage this condition. Currently there is very little understanding as to how Barrett's esophagus develops and why some people with Barrett's esophagus go on to develop esophageal cancer. The purpose of this study is to develop a better understanding of how these processes occur. The investigators also hope to use the information from this study to identify new molecular markers that the investigators can use to better determine who will or will not go on to develop esophageal cancer. Patients who have been diagnosed in the past with Barrett's esophagus will be asked to participate. Patients without Barrett's esophagus will be asked to take part so that the investigators can compare tissue from patients without the conditions to those with the conditions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Barrett's Esophagus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

With Barrett's Esophagus

Patients who have been diagnosed in the past with Barrett's Esophagus

No interventions assigned to this group

Without Barrett's Esophagus

Patients without Barrett's Esophagus will be asked to take part so that comparison can be made with patients' tissue for those with the condition and those without the condition.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For BE patients:

* History of histologically confirmed BE, defined as endoscopically-suspected BE with intestinal metaplasia with globlet cells on esophageal biopsies,
* BE length C1M1 or C0M2
* Age 18 years

Exclusion Criteria

* History of gastric or esophageal surgery
* Inability to give informed consent
* Erosive esophagitis seen on upper endoscopy
* History of prior endoscopic therapy for BE 5 (for controls) History of intestinal metaplasia on previous esophageal, GE junction or cardia biopsies.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No